Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Supplemental Figure S5 from [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study

作者:Austin R. Pantel, Sarah B. Gitto, Mehran Makvandi, Hyoung Kim, Sergey Medvedev, Joanna K. Weeks, Drew A. Torigian, Chia‐Ju Hsieh, Benjamin Ferman, Nawar Latif, János L. Tanyi, Lainie P. Martin, Shannon M. Lanzo, Fang Liu, Quy Cao, Gordon B. Mills, Robert K. Doot, David A. Mankoff, Robert H. Mach, Lilie L. Lin, Fiona Simpkins · 年份:2025 · DOI:10.1158/1078-0432.30707123 · 研究领域:PARP inhibition in cancer therapy、Ovarian cancer diagnosis and treatment、Estrogen and related hormone effects

<p>Clinical response correlates.</p>